相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。In vivo Dynamics and Distinct Functions of Hypoxia in Primary Tumor Growth and Organotropic Metastasis of Breast Cancer
Xin Lu et al.
CANCER RESEARCH (2010)
PTEN Loss Contributes to Erlotinib Resistance in EGFR-Mutant Lung Cancer by Activation of Akt and EGFR
Martin L. Sos et al.
CANCER RESEARCH (2009)
Mitogen-Activated Protein Kinase Phosphatase-1 in Human Breast Cancer Independently Predicts Prognosis and Is Repressed by Doxorubicin
Federico Rojo et al.
CLINICAL CANCER RESEARCH (2009)
AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001
Marin Marinov et al.
CLINICAL CANCER RESEARCH (2009)
ErbB receptors and signaling pathways in cancer
Nancy E. Hynes et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
Elevated expression of DKK1 is associated with cytoplasmic/nuclear β-catenin accumulation and poor prognosis in hepatocellular carcinomas
Bin Yu et al.
JOURNAL OF HEPATOLOGY (2009)
A critical role for Rac1 in tumor progression of human colorectal adenocarcinoma cells
Carolina Espina et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Negative-feedback regulation of FGF signalling by DUSP6/MKP-3 is driven by ERK1/2 and mediated by Ets factor binding to a conserved site within the DUSP6/MKP-3 gene promoter
Maria Ekerot et al.
BIOCHEMICAL JOURNAL (2008)
Dual-specificity MAP kinase phosphatases (MKPs) and cancer
Stephen M. Keyse
CANCER AND METASTASIS REVIEWS (2008)
WT1 induction of mitogen-activated protein kinase phosphatase 3 represents a novel mechanism of growth suppression
Debra J. Morrison et al.
MOLECULAR CANCER RESEARCH (2008)
Somatic mutations affect key pathways in lung adenocarcinoma
Li Ding et al.
NATURE (2008)
Targeting RAS and PI3K in lung cancer
Julian Downward
NATURE MEDICINE (2008)
Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas
Takumi Yamabuki et al.
CANCER RESEARCH (2007)
hEGR1 is induced by EGF, inhibited by gefitinib in bladder cell lines and related to EGF receptor levels in bladder tumours
J. E. Nutt et al.
BRITISH JOURNAL OF CANCER (2007)
p38 alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation
Juan Jose Ventura et al.
NATURE GENETICS (2007)
Urokinase plasminogen activator and plasminogen activator inhibitor type-1 in nonsmall-cell lung cancer: Relation to prognosis and angiogenesis
Birgitte Vrou Offersen et al.
LUNG CANCER (2007)
Computer-assisted analysis of biopsy specimen microvessels predicts the outcome of esophageal cancers treated with chemoradiotherapy
SC Zhang et al.
CLINICAL CANCER RESEARCH (2006)
Multiple oncogenic changes (K-RASV12, p53 knockdown, mutant EGFRs, p16 bypass, telomerase) are not sufficient to confer a full malignant phenotype on human bronchial epithelial cells
M Sato et al.
CANCER RESEARCH (2006)
MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer
S. Chattopadhyay et al.
ONCOGENE (2006)
Angiogenesis in life, disease and medicine
P Carmeliet
NATURE (2005)
Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer
F Renyi-Vamos et al.
CLINICAL CANCER RESEARCH (2005)
Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels
YL He et al.
CANCER RESEARCH (2005)
Mitogen-activated protein kinases in apoptosis regulation
T Wada et al.
ONCOGENE (2004)
The mature bone morphogenetic protein-2 is aberrantly expressed in non-small cell lung carcinomas and stimulates tumor growth of A549 cells
EM Langenfeld et al.
CARCINOGENESIS (2003)
A multigenic program mediating breast cancer metastasis to bone
YB Kang et al.
CANCER CELL (2003)
Expression of mitogen-activated protein kinase phosphatase-1 (MKP-1) in primary human ovarian carcinoma
C Denkert et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases
GL Johnson et al.
SCIENCE (2002)
Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling
YL He et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
Mitogen-activated protein (MAP) kinase pathways: Regulation and physiological functions
G Pearson et al.
ENDOCRINE REVIEWS (2001)
Mammalian MAP kinase signalling cascades
LF Chang et al.
NATURE (2001)
CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin
I Sánchez-Pérez et al.
ONCOGENE (2000)
Signal transduction by the JNK group of MAP kinases
RJ Davis
CELL (2000)
Protein phosphatases and the regulation of mitogen-activated protein kinase signalling
SM Keyse
CURRENT OPINION IN CELL BIOLOGY (2000)
分享论文
